Ilaria Iacobucci

31PUBLICATIONS
344CO-AUTHORS
Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)AutoimmunityLife historiesLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jul 01, 2026
FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia.

|Apr 06, 2026
The ASH HematOmics Program supports integrative analysis of genomic and clinical data in hematologic diseases.

Congyu Lu, Gavriel Y Matt, Robin Paul

|Mar 27, 2026
IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response.

Sonja Bendig, Alina M Hartmann, Wiebke Wessels

|Mar 06, 2026
Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Danika Di Giacomo, Petri Pölönen, Valentina Bardelli

|Jan 23, 2026
DHODH as a targetable metabolic Achilles' heel for chemotherapy-resistant B-ALL.

Yuxuan Liu, Haowen Jiang, Jingjing Liu

|Aug 14, 2025
Venetoclax plus gilteritinib is effective in preclinical models of FLT3-mutant BCL11B-a lineage-ambiguous leukemia.

Lindsey E Montefiori, Ilaria Iacobucci, Qingsong Gao

Pageof 6

Frequent Collaborators

26 joint publications

Charles G Mullighan

9 joint publications

Qingsong Gao

6 joint publications

Stanley Pounds

5 joint publications

Shunsuke Kimura